Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, Mohsen Naghavi, Kyle J Foreman et al. · The Lancet · 2012 · 14.3K citations · Full text

Public Health, Health Sciences, Epidemiologic Methods +16

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Christopher J L Murray, Theo Vos, Rafael Lozano et al. · The Lancet · 2012 · 9K citations

Public Health, Health Sciences, Public Health Practice +17

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

Medicine, Oncology, Pharmacology +17

1,026 Experimental treatments in acute stroke

Victoria O’Collins, Malcolm Macleod, Geoffrey A. Donnan et al. · Annals of Neurology · 2006 · 1.5K citations

Medicine, Neurology, Pharmacotherapy +17

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

The Lancet · 2012 · 1.2K citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +13